Form 4 · Filed Jul 17, 2026, 01:58 AM UTC
INM/InMed Pharmaceuticals Inc.
Vivo Opportunity, LLC — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | P | buy | 19 | $2 | $29 | 743,057 |
| Jul 16, 2026 | P | buy | 2 | $2 | $3 | 75,019 |
| Jul 15, 2026 | P | buy | 13,761 | $2 | $21,330 | 743,038 |
| Jul 15, 2026 | P | buy | 1,389 | $2 | $2,153 | 75,017 |
| Jul 14, 2026 | P | buy | 4,882 | $2 | $7,567 | 729,277 |
| Jul 14, 2026 | P | buy | 493 | $2 | $764 | 73,628 |
Source: SEC EDGAR raw filing ↗ · Accession 0001213900-26-078891